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Bioactivity of oregano methanolic extracts and essential oils is well known. Nonetheless, reports using
aqueous extracts are scarce, mainly decoction or infusion preparations used for therapeutic applications.
Herein, the antioxidant and antibacterial activities, and phenolic compounds of the infusion, decoction
and hydroalcoholic extract of oregano were evaluated and compared. The antioxidant activity is related
with phenolic compounds, mostly ﬂavonoids, since decoction presented the highest concentration of
ﬂavonoids and total phenolic compounds, followed by infusion and hydroalcoholic extract. The samples
were effective against gram-negative and gram-positive bacteria. It is important to address that the hydro-
alcoholic extract showed the highest efﬁcacy against Escherichia coli. This study demonstrates that the
decoction could be used for antioxidant purposes, while the hydroalcoholic extract could be incorporated
in formulations for antimicrobial features. Moreover, the use of infusion/decoction can avoid the toxic
effects showed by oregano essential oil, widely reported for its antioxidant and antimicrobial properties.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Plants are used since ancient times by primitive societies due to
therapeutic and psychotherapeutic beneﬁts, among other healing
properties. In recent years, it has been observed an increasing inter-
est for biological properties of medicinal plants, in order to identify
and evaluate their therapeutic potential, and also to identify the
major bioactive compounds and possible synergisms (Albano &
Miguel, 2011; Bakkali, Averbeck, Averbeck, & Idaomar, 2008).
Origanum vulgare L. (oregano) is an herbaceous, perennial and
very tough plant, belonging to the Lamiaceae (lipped) family. It is
used, since ancient times, for medicinal purposes and, in particular,
the antioxidant properties of O. vulgaremethanolic extract (Barros,
Heleno, Carvalho, & Ferreira, 2010; Economou, Oreopoulou, &
Thomopoulos, 1991; Kaurinovic, Popovic, Vlaisavljevic, &
Trivic, 2011; Kosar, Dorman, & Hiltunen, 2005; Spiridon, Bodirlau,
& Teaca, 2011; Özbek et al., 2008; Sahin et al., 2004; Škerget et al.,
2005) and essential oils (Alinkina, Misharina, & Fatkullina, 2012;
Cekera et al., 2012; Quiroga et al., 2013; Sahin et al., 2004) have
been reported. Nevertheless, studies using aqueous extracts arescarce (Licˇina et al., 2013), especially in decoction or infusion prep-
arations traditionally used due to digestive, expectorant, antiseptic
and antispasmodic properties (Vanaclocha & Cañigueral, 2003).
Some studies reported antibacterial activity of O. vulgare infusion
and decoction (Chaudhry, Saeed, & Tariq, 2007; Saeed & Tariq,
2009), but using high concentrations (200 mg/mL and 100 mg/
mL, respectively). In fact, the majority of reports regarding oregano
antibacterial activity used essential oils (Bakkali et al., 2008;
Orhan, Özçel_Ik, Kartal, & Kan, 2012; Rosato et al., 2009; Vale-Silva
et al., 2012; Vanaclocha & Cañigueral, 2003; Viuda-Martos,
Ruiz-Navajas, Fernandez-Lopez, & Perez-Alvarez, 2007), which in
some cases are toxic and non-tolerated by patients. In general,
essential oils tend to have side effects, in different degrees, and
for this reason they should never be used undiluted. Oregano
essential oil is an example, and despite its wide variety of applica-
tions, it could be used both internally and topically, but its applica-
tion should be used with same precaution, due to photosensitive,
neurotoxic and hepatotoxic effects. The main compounds present
in oregano essential oil are phenolic monoterpenes, carvacrol and
thymol (Bakkali et al., 2008; Sivropoulou, 1996). Those substances,
at therapeutic doses, are beneﬁcial during a small period of time,
but they can be toxic to liver, kidneys and nervous system if taken
in excess. According to Tisserand and Balacs (1995), oregano
essential oil is never topically applied to mucous membranes in
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to the skin and even a possible burning effect. The same precaution
should also be taken with individuals who have very sensitive or
damaged skin, as well as with children less than two years of
age, and during pregnancy, in which the oil application is not rec-
ommended (Longe, 2005; Tisserand & Balacs, 1995; Vanaclocha &
Cañigueral, 2003). The most important cases in which the use of
oregano essential oil is not recommend include patients with gas-
tritis, gastroduodenal ulcers, ulcerative colitis and other inﬂamma-
tory bowel diseases, liver disease, epilepsy, Parkinson’s disease or
other neurological dysfunctions. Furthermore, oregano essential
oil should be used with caution in cases of patients with epilepsy,
due to their potential neurotoxic and convulsing effects. Despite
the absence of clinical studies, there are a few reports on the side
effects of oregano essential oil. Cleff et al. (2008), evaluated the
toxicity of O. vulgare essential oil administered orally and with
intravaginal applications during 30 days, in adult females and Wis-
tar rats, and concluded that 3% of the essential oil did not results in
toxicological alterations. However, the authors recommend other
studies namely, with different concentrations. Thus, oregano
essential oil can be considered safe, when used correctly, never
being taken internally, and topical applications should be
performed after dilution, in a suitable carrier oil, and in low doses
over a short period of time.
Therefore, the identiﬁcation and characterization of other bio-
active molecules (e.g., phenolic compounds) beside essential oils
is demanded, particularly in forms (decoction and infusion) tradi-
tionally used for therapeutic applications. The aim of this work
was to assess antioxidant and antibacterial efﬁcacy of decoction,
infusion and hydroalcoholic extract of O. vulgare and to carry out
identiﬁcation of main beneﬁcial compounds, in terms of phenolic
composition.2. Materials and methods
2.1. Sample
Flowering aerial parts (leaves and ﬂowers, separated from
branches) of Origanum vulgare L., previously dried, supplied by Sor-
ia Natural (Garray – Soria, Spain), were obtained in September
2012. The sample was a clean product, with monitored parameters
of pesticides, herbicides, heavy metals and radioactivity.
2.2. Standards and reagents
Methanol was of analytical grade purity and supplied by Prona-
lab (Lisbon, Portugal). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was
obtained fromAlfa Aesar (WardHill, MA, USA). HPLC-grade acetoni-
trile was obtained fromMerck KgaA (Darmstadt, Germany). Formic
and acetic acids were purchased from Prolabo (VWR International,
France). The phenolic compound standards (apigenin 6-C-glucoside,
chlorogenic acid, eriodictyol, kaempferol 3-O-glucoside, luteolin 7-
O-glucoside, myricetin, protocatechuic acid, quercetin 3-O-gluco-
side, quercetin 3-O-rutinoside, rosmarinic acid, taxifolin) were from
Extrasynthese (Genay, France). Trolox (6-hydroxy-2,5,7,8-tetrame-
thylchroman-2-carboxylic acid) was purchased from Sigma Chemi-
cal Co. (St. Louis, MO, USA). Water was treated in a Milli-Q water
puriﬁcation system (TGI Pure Water Systems, Greenville, SC, USA).
2.3. Preparation of the infusion, decoction and hydroalcoholic extract
Hydroalcoholic extraction was performed using the plant mate-
rial (1 g) stirring with 30 mL of methanol:water (80:20, v/v) at
25 C and 150 rpm for 1 h, and ﬁltered through Whatman No. 4
paper. The residue was then extracted with one additional 30 mLportion of the hydroalcoholic mixture. The combined extracts were
evaporated at 35 C under reduced pressure (rotary evaporator
Büchi R-210, Flawil, Switzerland) and then further lyophilized
(FreeZone 4.5, Labconco, Kansas City, MO, USA).
For infusion preparation, the sample (1 g) was added to 200 mL
of boiling distilled water and left to stand at room temperature for
5 min, and then ﬁltered under reduced pressure. For decoction
preparation, the sample (1 g) was added to 200 mL of distilled
water, heated (heating plate, VELP scientiﬁc) and boiled for
5 min. The mixture was left to stand for 5 min and then ﬁltered
under reduced pressure. The obtained infusions and decoctions
were frozen and lyophilized. The lyophilized hydroalcoholic
extract, was re-dissolved in methanol:water (80:20, v/v), while
the infusion and decoction were re-dissolved in water, to obtain
stock solutions of 20 mg/mL.
2.4. Evaluation of bioactivity
2.4.1. Antioxidant activity
Four different in vitro assays were performed using serial dilu-
tions of stock solution: scavenging effects on DPPH (2,2-diphe-
nyl-1-picrylhydrazyl) radicals (RSA); reducing power (measured
by ferricyanide Prussian blue assay) (RP); inhibition of b-carotene
bleaching (CBI); and inhibition of lipid peroxidation in brain cell
homogenates by TBARS (thiobarbituric acid reactive substances)
assay (LPI).
RSA was evaluated using an ELX800 microplate Reader (Bio-Tek
Instruments, Inc; Winooski, VT, USA), and calculated as a percent-
age of DPPH discolouration through the formula: [(ADPPH–AS)/
ADPPH]  100, where AS is the absorbance of the solution containing
the sample at 515 nm, and ADPPH is the absorbance of the DPPH
solution. RP was evaluated by the capacity to convert Fe3+ into
Fe2+, measuring the absorbance at 690 nm in the microplate Reader
mentioned above. CBI was evaluated though the b-carotene/linole-
ate assay; the neutralization of linoleate free radicals avoids b-car-
otene bleaching, which is measured by the formula: b-carotene
absorbance after 2 h of assay/initial absorbance)  100. LPI in pig
(Sus scrofa) brain homogenates was evaluated by the decreasing
in thiobarbituric acid reactive substances (TBARS); the color inten-
sity of the malondialdehyde-thiobarbituric acid (MDA-TBA) abduct
was measured by its absorbance at 532 nm; the inhibition ratio (%)
was calculated using the following formula: [(A – B)/A]  100%,
where A and B were the absorbance of the control and the sample
solution, respectively. The results were expressed in EC50 values,
i.e. sample concentration providing 50% of antioxidant activity or
0.5 of absorbance in the reducing power assay (Barros et al., 2010).
2.4.2. Antibacterial activity
To evaluate antibacterial activity different bacteria strains from
American Type Culture Collection (ATCC) were used, namely Gram
positive species, Staphylococcus aureus (ATCC 25923) and Staphylo-
coccus epidermidis (ATCC 35983), and Gram negative species, Esch-
erichia coli (ATCC 25922), Klebsiella spp., Pseudomonas aeruginosa
(ATCC 10145), Enterococcus aerogenes (ATCC 2048), Proteus vulgaris
(ATCC 6380) and Enterobacter sakazakii (ATCC 29544). The antibac-
terial effect was evaluated using the disc diffusion halo test
(NCCLS/CLSI & ANVISA, 2003). For that, each species was cultivated
in a liquid medium, containing 30 mL of Tryptic Soy Broth (TSB),
during 24 h. After that, the concentration of each species was
normalized for 0.5 of optical density (with approximately 1  107
cells/mL) by absorbance determination at 600 nm. An aliquot of
each species (300 lL) was spread in Tryptic Soy Agar (TSA) petri
dishes. Then, an aliquot of 25 lL of each sample (decoction, infu-
sion and hydroalcoholic extract-20 mg/mL), was placed on sterile
blank disc. Sterile water was used as negative control. The plates
were incubated at 37 C, during 24-48 h. Antibacterial activity
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assay. In this study, the qualitative results were converted in a
semi-quantitative scale being classiﬁed the distinctness of the halo
as: () absence of halo; (+) weak halo; (++) moderate halo; (+++)
strong halo. Absence of halo concerning to 0.0 mm; weak halo be-
tween 0.3 and 0.7 mm; moderate halo 8–1.0 mm, and strong halo
greater than 1.1 mm.
2.5. Analysis of phenolic compounds
Phenolic compounds were determined by HPLC (Hewlett-Pack-
ard 1100, Agilent Technologies, Santa Clara, CA, USA) as previously
described by Barros et al. (2013a). Double online detection was car-
ried out in the diode array detector (DAD) using 280 nmand 370 nm
as preferred wavelengths and in a mass spectrometer (MS) con-
nected to the HPLC system via the DAD cell outlet. The phenolic
compounds present in the samples were characterised according
to their UV and mass spectra and retention times compared with
commercial standards when available. The phenolic compounds
were identiﬁed by comparing their retention time, UV–vis andmass
spectra with those obtained from standard solutions, when avail-
able. Otherwise, peaks were tentatively identiﬁed comparing the
obtained information with available data reported in the literature.
For quantitative analysis, a calibration curve (1–100 g/mL) for each
available phenolic standard was constructed based on the UV
signal: apigenin-6-C-glucoside (y = 517.4x + 268.26; R2 = 0.9921);
chlorogenic acid (y = 313.03x  58.2; R2 = 0.999); kaempferol 3-O-
glucoside (y = 288.55x  4.0503; R2 = 1); kaempferol 3-O-rutino-
side (y = 239.16x  10.587; R2 = 1); luteolin 7-O-glucoside
(y = 80.829x 21.291; R2 = 0.999); myricetin (y = 741.41x 221.6;
R2 = 0.999); protocatechuic acid (y = 291.1x  6.4558; R2 = 0.999);
quercetin 3-O-glucoside (y = 363.45x + 117.86; R2 = 0.9994), quer-
cetin 3-O-rutinoside (y = 281.98x  0.3459; R2 = 1); rosmarinic acid
(y = 336.03x + 170.39; R2 = 0.999) and taxifolin (y = 478.06x +
657.33; R2 = 0.999). For the identiﬁed phenolic compounds for
which a commercial standard was not available, the quantiﬁcation
was performed through the calibration curve of other compound
from the same phenolic group. The results were expressed in mg
per g of extract.
2.6. Statistical analysis
All the samples of oregano (infusion, decoction and hydroalco-
holic extract) were prepared and analyzed in triplicate. The results,
expressed as mean values and standard deviation (SD), were ana-
lyzed using one-way analysis of variance (ANOVA) followed by
Turkey’s HSD Test with a = 0.05, performed with SPSS (Statistical
Package for the Social Sciences) v. 22.0 program (IBM).
3. Results and discussion
3.1. Evaluation of antioxidant activity
The antioxidant properties were evaluated by determining
reducing power (RP), free radicals scavenging activity (RSA),Table 1
Antioxidant activity (EC50 values, lg/mL) of infusion, decoction and hydroalcoholic extrac
Infusion
DPPH scavenging activity (RSA) 142.43 ± 10.30a
Reducing power (RP) 116.26 ± 0.45a
b-carotene bleaching inhibition (CBI) 262.30 ± 2.58b
TBARS inhibition (LPI) 22.75 ± 0.54b
EC50 values correspond to the sample concentration providing 50% of antioxidant activity
lower antioxidant activity.
In each row different letters mean signiﬁcant differences (p < 0.05).b-carotene bleaching inhibition (CBI) and lipid peroxidation inhibi-
tion (LPI) in brain cell homogenates. The results are shown in
Table 1. The infusion and decoction samples presented similar RP
and RSA, but the decoction gave higher CBI and LPI than the infu-
sion. Both preparations (infusion and decoction) gave, in all the
performed assays, higher antioxidant activity than the hydroalco-
holic extract. Therefore, the compounds with stronger antioxidant
activity in oregano seem to be water-soluble.
It should be highlighted that infusions can be used in a wide
range of medical conditions by the majority of people without
causing any adverse/toxic effect, not only by internal but also by
external use (EFSA, 2010). Nevertheless, European Commission
and other health organizations consider that due to the lack of
an adequate dossier, the safety of oregano and other medicinal
plants cannot be assessed (EFSA, 2010). Thus, their use for medic-
inal purposes should be avoided in the absence of therapeutic indi-
cations. However, it should be noted that the use of oregano as
spice, herbal food ingredient and in folk medicine has a safe
history, being cited since ancient times (Longe, 2005; Vanaclocha
& Cañigueral, 2003). In fact, due to the extensive culinary use, oreg-
ano is listed as Generally Recognised As Safe (GRAS), in the Code of
Federal Regulations (http://www.ecfr.gov/cgi-bin/ECFR) and had
never been restricted by any worldwide authority. European Food
and Safety Authority (EFSA) reports a high antioxidant efﬁcacy of
oregano as food additive, but without a dossier supporting its
use and reporting safety levels (EFSA, 2010).
Alinkina et al. (2012) described a higher antioxidant activity of
oregano essential oils compared to individual phenols (thymol and
carvacrol), which means that other important compounds have
interactions and establish a synergic effect. Similar results were
shown by Quiroga et al. (2013), comparing the chemical composi-
tion, antioxidant and anti-lipase activities of O. vulgare and Lippia
turbinate essential oils. The authors concluded that, despite the
similarity in the antioxidant activity of both essential oils, oregano
showed higher anti-lipase and scavenging activities than Lippia,
attributing those properties to its higher phenolic content. Sahin
et al. (2004) also described strong free radicals scavenging proper-
ties of oregano methanolic extract (due to phenolic content), but a
weaker activity of its essential oils. They also observed that a meth-
anolic extract did not effectively inhibited linoleic acid oxidation
(Sahin et al., 2004). This should be in agreement with our study,
in which the hydroalcoholic extract showed lower inhibitory activ-
ity of b-carotene bleaching (CBI EC50 371.45 ± 12.40 lg/mL) than
radical scavenging activity (RSA value 246.45 ± 24.00 lg/mL).
Other authors, reporting the antioxidant activity of some plant
extracts of the family Lamiaceae, including oregano, attributed
their scavenging activity to phenolic and ﬂavonoid contents
(Economou et al., 1991; Kaurinovic et al., 2011; Spiridon et al.,
2011; Škerget et al., 2005). Furthermore, Kaurinovic et al. (2011)
also described strong antioxidant effects for oregano aqueous
extracts in comparison with organic extracts, which is in
accordance with our experiment where decoction and infusion
gave higher antioxidant activity than the hydroalcoholic extract.
The antioxidant activity reported by Barros et al. (2010) for a meth-
anolic extract obtained from wild oregano was, in general, highert of Origanum vulgare L. (mean ± SD).
Decoction Hydroalcoholic extract
132.93 ± 6.61a 246.45 ± 24.00b
111.06 ± 8.16a 237.45 ± 8.51b
115.69 ± 16.34c 371.45 ± 12.40a
8.73 ± 0.55c 33.66 ± 2.93a
or 0.5 of absorbance in the reducing power assay. Higher EC50 values correspond to
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antioxidant properties of infusion/decoction.
3.2. Evaluation of antibacterial activity
The results obtained in the screening of antibacterial activity by
disc diffusion halo assay are present in Table 2. The results
revealed that the samples were, in general, effective against the
gram-negative and gram-positive bacteria tested, despite the most
pronounced effect was observed against the gram-negative bacte-
ria, speciﬁcally E. coli and P. aeruginosa. It was very interesting to
observe the variability among the different species of the same
genus tested, namely Enterobacter spp. and Staphilococcus spp,
gram-negative and gram-positive bacteria, respectively. In fact,
the effect was opposite in the two species of each genus.
Decoction and infusion had similar potential against almost all
the tested bacteria, whereas the hydroalcoholic extract showed
relatively higher efﬁcacy against some strains (namely, E. coli and
P. vulgaris) than the former. Chaudhry et al. (2007), using an essen-
tial oil, infusion and decoction of oregano, reported inhibitory
effects against gram-negative bacteria (Aeromonas hydrophila,
Citrobacter spp., E. aerogenes, E. coli, Flavobacterium spp., Klebsiella
ozaenae, Klebsiella pneumoniae, P. mirabilis, P. aeruginosa, Salmonella
typhi, S. paratyphi B, Serratia marcescens and Shigella dysenteriae).
The highest inhibitory activity was obtained using essential oil
against Citrobacter spp., whereas infusion showed inhibitory activ-
ity against all type of bacteria strains, namely Klebsiella pneumonia,
Klebsiella ozaenae and Enterobacter aerogenes. All the bacteria
showed resistance to oregano decoction. Despite in our experiment
no antibacterial activity has been detected against Klebsiella spp., it
should be highlighted that the concentration used (20 mg/mL) was
considerably lower than the tested by those authors (200 mg/mL)
(Chaudhry et al., 2007). Moreover, the results obtained under this
study showed antibacterial activity by the decoction (20 mg/mL)
against E. aerogenes, E. coli and P. aeruginosa. Saeed and Tariq
(2009) found that the infusion was more effective than the essen-
tial oil of oregano against gram-positive bacteria (Staphylococcus
saprophyticus, S. aureus, Micrococcus roseus, M. kristinae, M. nish-
inomiyaensis, M. lyla, M. luteus, M. sedentarius, M. varians, Bacillus
megaterium, B. thuringiensis, B. alvei, B. circulans, B. brevis, B. coagu-
lans, B. pumilus, B. laterosporus, B. polymyxa, B. macerans, B. subtilis,
B. ﬁrmus, B. cereus and B. lichiniformis) whereas no antibacterial
activity was found using oregano decoction (100 mg/mL).
3.3. Analysis of phenolic compounds
The phenolic proﬁle of O. vulgare, obtained after hydroalcoholic
extraction, and recorded at 370 nm is shown in Fig. 1; peak charac-
teristics and tentative identities are presented in Table 3. Twenty
two compounds were detected, six of which were phenolic acid
derivatives and sixteen ﬂavonoids. Protocatechuic (peak 2),
5-O-caffeoylquinic (peak 3) and rosmarinic acid (peak 15) were
positively identiﬁed according to their retention, mass andTable 2
Antibacterial activity of infusion, decoction and hydroalcoholic extract of Origanum vulgar
Antibacterial activity Infusion (20 mg/mL)
Gram positive Staphylococcus aureus 
Staphylococcus epidermidis +
Gram negative Escherichia coli ++
Klebsiella spp. 
Pseudomonas aeruginosa +
Enterobacter aerogenes 
Enterobacter sakazakii +
Proteus vulgaris +
() absence of halo; (+) weak halo; (++) moderate halo; (+++) strong halo.UV–vis characteristics by comparison with commercial standards.
Peak 1 ([M–H] at m/z 353) was identiﬁed as 3-O-caffeoylquinic
acid, yielding the base peak at m/z 191 and the ion at m/z 179 with
an intensity >66% base peak, characteristic of 3-acylchlorogenic
acids as reported by Clifford, Johnston, Knight, and Kuhnert
(2003) and Clifford, Knight, & Kuhnert, 2005). Peak 8 presented a
pseudo molecular ion [M–H] at m/z 421, yielding a unique frag-
ment ion at m/z 153. Nakatani and Kikuzaki (1987) identiﬁed a
compound with the same molecular weight in O. vulgare as
4-(3,4-dihydroxybenzoyloxymethyl)phenyl-b-D-glucopyranoside
and recently, Zhang et al. (2014) also identiﬁed and isolated a sim-
ilar compound in O. vulgare, with the same molecular weight and
UV spectra, as 4-[[(20,50-dihydroxybenzoyl)oxy]methyl]phenyl
O-b-D-glucopyranoside. A compound with the same mass and UV
characteristics was also identiﬁed by Miron, Plaza, Bahrim, Ibáñez,
and Herrero (2011) as protocatechuic acid hexoside, although such
a structure should be wrong as it does not match with its molecu-
lar ion and no discussion is made in the paper about the reasons for
giving that identity. Furthermore, it would not be logical a hexo-
side elute later than the parent phenolic acid. Thus, the peak could
be assigned as 4-[[(20,50-dihydroxybenzoyl)oxy]methyl]phenyl
O-b-D-glucopyranoside, due to its similar UV and MS spectra.
Peak 19 presented a pseudo molecular ion [M–H] at m/z 537
and a UV spectrum and fragmentation pattern consistent with
the caffeic acid trimer lithospermic acid A. This compound can eas-
ily lose 8’’-carboxyl group (-44 mu) releasing a fragment atm/z 493
that further breaks down to form the fragment ions at m/z 313 and
295 (Barros et al., 2013b). Salvianolic acids H/I, with the same
molecular weight as lithospermic acid A, were discarded as possi-
ble identities because they present quite a different fragmentation
pattern (Ruan, Li, Li, Luo, & Kong, 2012).
Myricetin 3-O-glucoside (peak 6), taxifolin (peak 9), quercetin
3-O-rutinoside (peak 10), luteolin 7-O-glucoside (peak 13),
eridictyol (peak 20) and naringenin (peak 22) were positively iden-
tiﬁed according to their retention, mass and UV–vis characteristics
by comparison with commercial standards.
Peak 12 presented a UV spectrum characteristic of luteolin (kmax
at 350 nm) and a pseudo molecular ion [M–H] at m/z 461, releas-
ing fragments at m/z 285 ([M-176], loss of a glucuronyl moiety),
being identiﬁed as luteolin O-glucuronide. Peaks 4, 14 and 16 were
identiﬁed as apigenin derivatives according to their UV and mass
spectra characteristics. Peak 4 presented a pseudo molecular ion
[M–H] at m/z 593, releasing three MS2 fragment ions at m/z 473
and 383, corresponding to the loss of 120 and 90 mu characteristic
of C-hexosyl ﬂavones, and at m/z 353 that would correspond to the
apigenin aglycone bearing some sugar residues [apigenin + 83 mu]
(Ferreres, Silva, Andrade, Seabra, & Ferreira, 2003). The fact that no
relevant fragment derived from the loss of a complete hexosyl
residue (162 mu) was detected suggested that both sugars were
C-attached, which allowed a tentative identiﬁcation of the com-
pound as apigenin C-hexoside C-hexoside. This compound can be
identiﬁed as apigenin 6,8-di-C-glucoside (vicenin-2) previously
identiﬁed in Origanum vulgare by Grevsen, Fretté, and Christensene L. against several bacterial species.
Decoction (20 mg/mL) Hydroalcoholic extract (20 mg/mL)
 
+ +
+ +++
 
++ ++
+ 
+ +
+ ++
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Fig. 1. Phenolic proﬁle of Origanum vulgare L. hydroalcoholic extract recorded at 370 nm (a) and 280 nm (b).
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to be a normal constituent of O. vulgare. Peaks 14 and 16 showed
pseudo molecular ions [M–H] at m/z 577 and 445, respectively,
both releasing an MS2 fragment at m/z 269 ([M-308] and
[M-176], respective losses of rutinosyl and glucuronyl moieties).
These compounds were tentatively assigned as apigenin 7-O-ruti-
noside and apigenin 7-O-glucuronide as they were previously iden-
tiﬁed in oregano by Hossain, Rai, Brunton, Martin-Diana, and
Barry-Ryan (2010) and Grevsen et al. (2009).
Peak 21 showed a pseudo molecular ion [M–H] at m/z 459,
releasing two MS2 fragments at 283 ([M-176], loss of a glucuronyl
moiety) and 268 (apigenin, further loss of a methyl residue), being
tentatively assigned as methylapigenin O-glucuronide. The pres-
ence of acacetin (40-O-methylapigenin) and another methylapige-
nin in oregano was reported by Hossain et al. (2010).
Pseudo molecular ([M–H] at m/z 463) and product (m/z at 301,
quercetin) ions of peaks 7 and 11 allowed their identiﬁcation as
quercetin O-hexosides. Peak 11 showed kmax at higher wavelength
(368 nm) than quercetin 3-O-glucoside (344 nm) and similar to
quercetin aglycone. According to Mabry, Markham, and Thomas
(1970), the introduction of a glycoside on the hydroxyls at
positions 7, 30 or 40 should not have effect on maximal wavelength
or the spectrum shape in relation to the aglycone. Thus, peak 11
was tentatively assigned as quercetin 7-O-hexoside. An undeﬁnedquercetin 3-O-hexoside was also reported to occur in oregano by
Hossain et al. (2010).
Peaks 5 and 17 were identiﬁed as kaempferol derivatives,
according to their UV and mass spectra characteristics. Peak 5
showed a pseudo molecular ion [M–H] at m/z 609, releasing two
MS2 fragments at m/z 447 ([M–H-162], loss of a hexosyl moiety)
and 285 (kaempferol; [M–H-162-162], loss of a further hexosyl
moiety), being identiﬁed as kaempferol O-hexosyl-O-hexoside.
Peak 17 presented a pseudo molecular ion at m/z 447 and a MS2
fragment at m/z 285 (kaempferol; [M–H-162-162], loss of a fur-
ther hexosyl moiety), being identiﬁed as kaempferol O-hexoside.
Peak 18 presented a pseudomolecular ion [M–H] atm/z 475, yield-
ing fragment ions atm/z 299 and 284, associated to the loss of a glu-
curonyl moiety (176 mu) and a further –CH3 group (15 mu), which
allowed its tentative identiﬁcation as kaempferide O-glucuronide.
From the 22 compounds identiﬁed, six were phenolic acids
being rosmarinic acid the most abundant in all the preparations.
The remaining compounds were ﬂavonoid derivatives, being lute-
olin 7-O-glucoside (hydroalcoholic acid) and luteolin O-glucuro-
nide (infusion and decoction) the most abundant compounds
found. Decoction presented the highest concentration of ﬂavonoids
(75.25 mg/g decoction) and total phenolic compounds (98.05 mg/g
decoction), followed by infusion and hydroalcoholic extract,
respectively. This is also in agreement with the results obtained
Table 3
Retention time (Rt), wavelengths of maximum absorption in the visible region (kmax), mass spectral data, identiﬁcation and quantiﬁcation of phenolic compounds in
hydroalcoholic extract, infusion and decoction of Origanum vulgare L.
Peak Rt
(min)
kmax
(nm)
Molecularion
[M–H] (m/z)
MS2 (m/z) Identiﬁcation Quantiﬁcation (mg/g extract)
Hydroalcoholic Infusion Decoction
1 5.79 328 353 191(100), 179(66), 173(4),
135(45)
3-O-Caffeolyquinic acid 0.37 ± 0.07 0.64 ± 0.01 0.55 ± 0.07
2 6.31 260,
sh294
153 123(8), 109(100) Protocatechuic acid 0.63 ± 0.06 1.07 ± 0.05 1.02 ± 0.06
3 8.67 328 353 191(100), 179(4), 173(2), 161(4),
135(2)
5-O-Caffeolyquinic acid 0.92 ± 0.04 0.96 ± 0.01 0.81 ± 0.03
4 11.75 330 593 473(16), 383(10), 353(16), 297(2) Apigenin 6,8-di-C-glucoside 0.52 ± 0.06 0.92 ± 0.00 0.98 ± 0.00
5 15.46 340 609 447(100), 285(12) Kaempferol O-hexosyl-O-hexoside 0.15 ± 0.01 0.22 ± 0.01 0.21 ± 0.01
6 17.12 360 479 317(100) Myricetin 3-O-glucoside 0.58 ± 0.01 0.52 ± 0.00 0.58 ± 0.00
7 18.01 344 463 301(100) Quercetin O-hexoside 0.41 ± 0.03 0.61 ± 0.02 0.57 ± 0.03
8 18.58 264,
sh290
421 153(100) 4-[[(2’,5’
Dihydroxybenzoyl)oxy]methyl]phenyl
O-b-D-glucopyranoside
3.46 ± 0.05 2.11 ± 0.16 2.54 ± 0.22
9 19.31 290 303 285(80), 125(100) Taxifolin 0.47 ± 0.02 0.31 ± 0.05 0.38 ± 0.38
10 19.91 354 609 301(100) Quercetin 3-O-rutinoside 3.71 ± 0.01 2.88 ± 0.02 3.16 ± 0.07
11 20.80 368 463 301(100) Quercetin 7-O-hexoside 0.54 ± 0.07 nd nd
12 21.12 350 461 285(100) Luteolin O-glucuronide 12.48 ± 0.09 26.50 ± 0.15 28.27 ± 0.24
13 21.32 348 447 285(100) Luteolin 7-O-glucoside 20.88 ± 0.00 22.93 ± 0.83 25.26 ± 0.44
14 24.12 332 577 269(100) Apigenin 7-O-rutinoside 1.53 ± 0.06 0.74 ± 0.00 1.09 ± 0.07
15 24.71 330 359 197(49), 179(45), 161(100),
135(21)
Rosmarinic acid 14.62 ± 0.03 15.91 ± 0.34 15.42 ± 0.15
16 25.87 338 445 269(100) Apigenin 7-O-glucuronide 5.78 ± 0.03 8.24 ± 0.48 8.63 ± 0.02
17 26.37 340 447 285(100) Kaempferol O-hexoside 1.30 ± 0.03 0.67 ± 0.21 0.76 ± 0.06
18 28.25 354 475 299(100), 284(47) Kaempferide O-glucuronide 1.58 ± 0.11 3.99 ± 0.03 3.97 ± 0.02
19 28.46 328 537 493(100), 359(88),313(10),
295(53), 197(16), 179(35),
161(73), 135(50)
Lithospermic acid A 2.33 ± 0.10 2.20 ± 0.05 2.45 ± 0.16
20 31.02 288 287 151(90), 135(100) Eridictyol 0.85 ± 0.01 0.22 ± 0.05 0.30 ± 0.08
21 35.01 342 459 283(100), 269(12) Methylapigenin O-glucuronide 1.26 ± 0.13 0.61 ± 0.02 0.79 ± 0.01
22 36.94 288,
sh334
271 151(90), 119(73) Naringenin 0.43 ± 0.04 0.17 ± 0.03 0.29 ± 0.01
Phenolic acids 22.33 ± 0.07a 22.89 ± 0.39a 22.80 ± 0.62a
Flavonoids 52.47 ± 0.18c 69.52 ± 0.74b 75.25 ± 0.54a
Total phenolic compounds 74.79 ± 0.11c 92.40 ± 0.35b 98.05 ± 1.16a
In each row different letters mean signiﬁcant differences (p < 0.05).
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activity. The concentration of phenolic acids did not present signif-
icant variation between the three different preparations.
There are several publications reporting the phenolic composi-
tion of O. vulgare from different origins and using different extrac-
tion methodologies. Nevertheless, none of those samples
exhibited the samephenolic proﬁle, presenting only few similarities
in some of the compounds identiﬁed (Agiomyrgianaki & Dais, 2012;
Grevsen et al., 2009; Hossain et al., 2010; Miron et al., 2011;
Rodríguez-Meizoso et al., 2006; Shen et al., 2010; Skoula, Grayer,
Kite, & Veitch, 2008). Miron et al. (2011) presented the phenolic
composition of O. vulgare from Romania after pressurized liquid
extraction with water and ethanol. Those authors identiﬁed twelve
compounds: eight phenolic acids namely, syringic acid, proto-
catechuic acid, protocatechuic glucoside, homovanillic acid,
hydroxybenzoic acid, caffeic acid, rosmarinic acid and caffeic acid
ethyl ester; and four ﬂavonoids namely, luteolin 7-O-glucuronide,
apigenin, luteolin, and naringenin. That study did not present any
quantiﬁcation, however, by the chromatographic proﬁle showed
in the paper, rosmarinic acid seemed to be the most abundant com-
pound. Rodríguez-Meizoso et al. (2006) studied dried oregano
leaves from Spain, using subcritical water extraction, but these
authors did not present any quantiﬁcation nor identiﬁcation of
the phenolic compounds, only proposing the chemical family for
some compounds (ﬂavanones, dihydroﬂavonols, ﬂavonols and ﬂav-
ones). Agiomyrgianaki and Dais (2012) analysed a sample ofO. vulg-
are from Greece, using ethanol and ethyl acetate as extraction
solvents. These authors identiﬁed and quantiﬁed nine phenolic
compounds namely, ferulic acid, apigenin, oleanolic acid, ursolicacid, rosmarinic acid, chlorogenic acid, naringenin, eriodictyol and
taxifolin. Shen et al. (2010) only described the presence of
rosmarinic, oleanolic and ursolic acids in samples of O. vulgare from
Greece and in another unspeciﬁc sample from Europe. Rosmarinic
acid was the most abundant compound found in all the studied
samples.
Skoula et al. (2008) reported the presence of fourteen phenolic
compounds in a sample from Greece, extracted with ethanol. That
study presented a variety of different phenolic compounds thatwere
not identiﬁed in theother studiesmentionedabove, andalso fromthe
ones identiﬁed herein. The authors presented four similar phenolic
compounds namely apigenin, naringenin, eriodictyol and taxifolin.
Moreover, Hossain et al. (2010) reported the presence of thirty
four phenolic compounds (fourteen phenolic acids, ﬁfteen
ﬂavonoids and ﬁve other phenolic compounds) in a sample from
Ireland, extracted with aqueous methanol (80%), using a homoge-
nizer and shaken overnight. The phenolic compounds identiﬁed
in this study presented similarities to the identiﬁcations performed
by Hossain et al. (2010), but some differences were observed, espe-
cially regarding phenolic acids. Grevsen et al. (2009) identiﬁed
nineteen phenolic compounds (ﬁve phenolic acids and fourteen
ﬂavonoids) in a sample of O. vulgare ssp. Hirtum (Greek oregano)
cultivated in cool temperature climate in Denmark. They
performed a similar extraction procedure as Hossain et al. (2010)
and the compounds identiﬁed were slightly similar to the ones
found in this study.
Overall, there is diversity in the characterization of the
phenolic compounds of samples from different countries and using
different extraction procedures. Nevertheless, the infusion and
N. Martins et al. / Food Chemistry 158 (2014) 73–80 79decoction of O. vulgare were never characterized nor quantiﬁed,
until now.
Both preparations, mostly decoction, gave higher antioxidant
activity than the hydroalcoholic extract. The antioxidant properties
seem to be related to phenolic compounds, mainly ﬂavonoids,
since decoction presented the highest concentration of ﬂavonoids
and total phenolic compounds, followed by infusion and hydroal-
coholic extract, respectively. Phenolic acids content (found in low-
er amounts in comparison with ﬂavonoids) did not varied among
different samples. Rosmarinic acid was the most abundant pheno-
lic acid in all the preparations, while luteolin 7-O-glucoside (hydro-
alcoholic acid) and luteolin O-glucuronide (infusion and decoction)
were the most abundant ﬂavonoids. Furthermore, all the samples
were effective against gram-negative and gram-positive bacteria,
but the most pronounced effect was observed against the gram-
negative bacteria, E. coli and P. aeruginosa. The hydroalcoholic
extract showed a higher efﬁcacy against some species namely,
E. coli and P. vulgaris, while decoction and infusion had similar
antimicrobial potential.
This study conﬁrms the bioactive potential of oregano besides
its use as food condiment; the decoction could be used for antiox-
idant purposes, while the hydroalcoholic extract could be incorpo-
rated in formulations for antimicrobial features. Moreover, the use
of infusion/decoction, by internal or external use, can avoid the
toxic effects showed by other oregano fractions such as essential
oil. Further studies should be performed in order to establish
in vivo bioactive properties.Acknowledgements
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